Work

The Lecanemab Clarity AD Open-Label Extension in Early Alzheimer’s Disease (P1-3.003)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000211489

Authors: Michael Irizarry, Christopher van Dyck, David Li, Shobha Dhadda, Steven Hersch, Larisa Reyderman, Lynn Kramer

Institutions: Eisai (United States), Yale University

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409228365

FWCI: 1.599

Cites:

Cited by: 3

Related to: 10